Dr. Jahansouz Shokri, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 485 Arsenal St, Internal Medicine, Watertown, MA 02472 Phone: 617-972-5240 Fax: 617-972-5512 |
News Archive
A study of patients, at the Christie Hospital, Manchester, has shown that the decision to fund patient care depends more on where the patient lives, than the patient's health circumstances, raising public concern regarding a "postcode lottery" since each decision is made solely by the patients' local Primary Care Trust (PCT). The findings of this study are published in a letter to Clinical Oncology.
Patients with drug-resistant epilepsy run the risk of gradual deterioration in their cognitive abilities. Surgical treatment generally puts an end to seizures but can have a negative effect on memory. However, there is no further deterioration in memory, and some patients may even recover some of their memory capacity, reveals a thesis from the University of Gothenburg.
Forbius announced today that it has been awarded a Product Development grant totaling $18.75 million from the Cancer Prevention and Research Institute of Texas.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Careā¢ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that CardioGenics Inc. and Merck Chimie S.A.S. have agreed on a plan to commercialize CardioGenics' proprietary paramagnetic beads, with shipments to Merck-Chimie's customers scheduled to start mid-September 2010.
› Verified 8 days ago